Article
Association of KLK3 (PSA) genetic variants with prostate cancer risk and PSA levels.
Carcinogenesis - 1 Jun 2011
Penney Kathryn L, Schumacher Fredrick R, Kraft Peter, Mucci Lorelei A, Sesso Howard D, Ma Jing, Niu Yuxin, Cheong Jit Kong, Hunter David J, Stampfer Meir J, Hsu Stephen I
Abstract excerpt
Genome-wide association studies have identified genetic markers in kallikrein-related peptidase 3 (KLK3) associated with prostate cancer. However, some of these markers are also associated with prostate-specific antigen (PSA) levels, so it is unclear whether the polymorphisms are causal or if the association with risk is solely due to detection bias through PSA screening. PSA is a biologically active serine...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
